Rangsubbs had a joint venture (Orberry) an Israel Pharma Company to launch the Psoriasis brand in India and the rest of the world. Our extensive focus in treating Psoriasis, Atopic Dermatitis (Eczema), Psoriatic Arthritis, Seborrheic Dermatitis, Pityriasisrosea.

Psoriasis Drugs Market Size Worth $21.11 Billion by 2022 | CAGR: 9.4% (September 2018 | Report Format: Electronic (PDF))

The global psoriasis drugs market size is expected to be valued at USD 21.11 billion by 2022, as per a new report by Grand View Research, Inc., experiencing a CAGR of 9.4% during the forecast period. Rising disease awareness, an increasing number of reimbursement strategies for biologics, and advanced diagnostic and technological tools are likely to increase the adoption of psoriasis therapeutics.

By April’2022 we are launching the Derma division for exclusive treatment for Psoriasis. This Patent Molecule we will be brought from Israel.